NVE Corporation (NVEC)vsZepp Health Corp (ZEPP)
NVEC
NVE Corporation
$82.79
+6.56%
TECHNOLOGY · Cap: $390.65M
ZEPP
Zepp Health Corp
$17.47
+4.55%
TECHNOLOGY · Cap: $247.54M
Smart Verdict
WallStSmart Research — data-driven comparison
Zepp Health Corp generates 898% more annual revenue ($258.90M vs $25.95M). NVEC leads profitability with a 54.6% profit margin vs -15.5%. NVEC earns a higher WallStSmart Score of 69/100 (B-).
NVEC
Strong Buy69
out of 100
Grade: B-
ZEPP
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-29.6%
Fair Value
$52.16
Current Price
$82.79
$30.63 premium
Margin of Safety
+48.6%
Fair Value
$46.70
Current Price
$17.47
$29.23 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Keeps 55 of every $100 in revenue as profit
Strong operational efficiency at 60.2%
Every $100 of equity generates 23 in profit
Growing faster than its price suggests
Revenue surging 22.9% year-over-year
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
Moderate valuation
Smaller company, higher risk/reward
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : NVEC
The strongest argument for NVEC centers on Profit Margin, Operating Margin, Return on Equity. Profitability is solid with margins at 54.6% and operating margin at 60.2%. Revenue growth of 22.9% demonstrates continued momentum.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : NVEC
The primary concerns for NVEC are P/E Ratio, Market Cap.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
NVEC profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.
ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.
ZEPP is growing revenue faster at 43.0% — sustainability is the question.
Monitor SEMICONDUCTORS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
NVEC scores higher overall (69/100 vs 41/100), backed by strong 54.6% margins and 22.9% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
NVE Corporation
TECHNOLOGY · SEMICONDUCTORS · USA
NVE Corporation develops and sells devices that use spintronics, a nanotechnology that relies on the spin of the electron to acquire, store, and transmit information in the United States and internationally. The company is headquartered in Eden Prairie, Minnesota.
Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other SEMICONDUCTORS Stocks
Want to dig deeper into these stocks?